Efficacy of Aflibercept for the treatment of diabetic macular oedema in patients refractory to Ranibizumab

被引：0
|
作者：
Clarke, Holly [1 ]
Sepetis, Anastasios [1 ]
Rennie, Christina [1 ]
Lotery, Andrew [1 ]
Sahu, Debendra [1 ]
Inzerillo, Dario [1 ]
Gupta, Bhaskar [1 ]
机构：
[1] Univ Hosp Southampton, Southampton, Hants, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3606
引用
收藏
页数：3
相关论文
共 50 条
  • [31] COMPARISON OF INTRAVITREAL AFLIBERCEPT, RANIBIZUMAB AND DEXAMETHASONE IMPLANT IN EYES WITH PERSISTENT DIABETIC MACULAR OEDEMA DESPITE PRIOR BEVACIZUMAB TREATMENT
    Spooner, Kimberly
    Hong, Thomas
    Chang, Andrew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 120 - 120
  • [32] A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)
    Stefanickova, Jana
    Cunha-Vaz, Jose
    Ulbig, Michael
    Pearce, Ian
    Fernandez-Vega Sanz, Alvaro
    Theodossiadis, Panagiotis
    Kodjikian, Laurent
    Izmailov, Alexander
    Muston, Dominic
    Vassilev, Zdravko
    Lamotte, Benedicte
    Tueckmantel, Claudia
    Friedl, Sabine
    Altemark, Andreas
    Schwarz, Hans-Joerg
    Katz, Todd
    ACTA OPHTHALMOLOGICA, 2018, 96 (08) : E942 - E949
  • [33] EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANT TREATMENT IN DIABETIC MACULAR EDEMA REFRACTORY TO INTRAVITREAL AFLIBERCEPT TREATMENT
    Celik, E.
    Sever, O.
    Cakir, B.
    Dogan, E.
    Ozmen, S.
    Atum, M.
    Aksoy, N.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP29 - NP29
  • [34] Real world use of aflibercept in treatment of diabetic macular oedema.
    McNally, Orla
    Williams, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [35] Ranibizumab in diabetic macular oedema: A Lanarkshire experience
    Luis, J.
    Lodhia, V.
    Virdi, M.
    Wong, K.
    Hasan, S.
    Chadha, V.
    Nabili, S.
    EYE, 2017, 31 : S16 - S17
  • [36] Impact of vitrectomy on outcomes of treatment for diabetic macular oedema with intravitreal ranibizumab
    Antao, Sheelah
    Fajgenbaum, Mark
    Patrao, Namritha Valerie
    Wong, Roger
    da Cruz, Lyndon
    Bainbridge, James W. B.
    Rajendram, Ranjan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [37] Pharmacodynamics of Ranibizumab treatment of center-involved diabetic macular oedema
    Hodzic-Hadzibegovic, Delila
    Sander, Birgit Agnes
    Lund-Andersen, Henrik
    Larsen, Michael
    ACTA OPHTHALMOLOGICA, 2014, 92 : 18 - 19
  • [38] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    T D Papakostas
    L Lim
    T van Zyl
    J B Miller
    B S Modjtahedi
    C M Andreoli
    D Wu
    L H Young
    I K Kim
    D G Vavvas
    D D Esmaili
    D Husain
    D Eliott
    L A Kim
    Eye, 2016, 30 : 79 - 84
  • [39] Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
    Demircan, Ali
    Alkin, Zeynep
    Yesilkaya, Ceren
    Demir, Gokhan
    Kemer, Burcu
    JOURNAL OF OPHTHALMOLOGY, 2018, 2018
  • [40] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    Papakostas, T. D.
    Lim, L.
    van Zyl, T.
    Miller, J. B.
    Modjtahedi, B. S.
    Andreoli, C. M.
    Wu, D.
    Young, L. H.
    Kim, I. K.
    Vavvas, D. G.
    Esmaili, D. D.
    Husain, D.
    Eliott, D.
    Kim, L. A.
    EYE, 2016, 30 (01) : 79 - 84
12345